High levels of YAP/TAZ expression are associated with reductions in metastasis-free survival in patients with breast cancer and adverse features of the disease [195]; TAZ is essential for sustaining the self-renewal of CD44+CD24−/low BCSCs [195]. This evidence concerns the gene CD24 and breast cancer.